CD5L
CD5L (CD5 molecule like, also known as Spalpha and API6) is a secreted protein of the scavenger receptor cysteine rich family. It is produced mainly by macrophages and regulates lipid synthesis and inflammatory responses. Browse Assay Genie's current range of CD5L research reagents below, or read on for the biology behind the target.
CD5L is a secreted protein that acts as a key regulator of lipid synthesis. It is expressed mainly by macrophages in lymphoid and inflamed tissues, where it shapes inflammatory responses such as those seen in infection or atherosclerosis. In adipocytes, CD5L is taken up by CD36-mediated endocytosis and associates with cytosolic FASN. This inhibits fatty acid synthase activity and leads to lipolysis, the breakdown of triacylglycerols into glycerol and free fatty acids. It can also reduce lipid droplet size, and CD5L-induced lipolysis accompanies the progression of obesity and obesity-associated inflammation.
The effects of CD5L on intracellular lipids feed into transcriptional control by the nuclear receptor ROR-gamma (RORC). In T-helper Th17 cells, CD5L acts as a regulator of the metabolic switch. It is mainly present in non-pathogenic Th17 cells, where it lowers polyunsaturated fatty acyl content and affects the metabolic proteins MSMO1 and CYP51A1. These proteins synthesise RORC ligands, so this limits RORC activity and the expression of pro-inflammatory genes. CD5L also associates with IgM, interferes with IgM binding to the Fcalpha/mu receptor and enhances the development of long-lived plasma cells that produce high-affinity IgG autoantibodies.
CD5L has further roles in survival and tissue repair. It protects macrophages from the apoptotic effects of oxidised lipids, and it contributes to the early response to microbial infection as a pattern recognition receptor that promotes autophagy. After acute kidney injury, it accumulates on necrotic debris and interacts with HAVCR1 on injured tubular epithelial cells, enhancing phagocytosis of that debris. The protein is also known as apoptosis inhibitor 6 (API6), and the gene belongs to the scavenger receptor cysteine rich domain containing group. NCBI Gene annotation predicts involvement in regulating complement activation and places the protein at the cell surface.
CD5L inhibits fatty acid synthase in adipocytes and drives lipolysis, linking it to obesity-associated inflammation and insulin resistance.
CD5L regulates lipid content and RORC ligand synthesis in Th17 cells, influencing expression of pro-inflammatory genes.
CD5L promotes macrophage survival against the apoptotic effects of oxidised lipids and regulates inflammatory responses in macrophages.
CD5L binds necrotic debris and interacts with HAVCR1, enhancing debris phagocytosis and promoting recovery from acute kidney injury.
CD5L is a secreted regulator of lipid synthesis made mainly by macrophages. It inhibits fatty acid synthase in adipocytes, restrains pro-inflammatory gene expression in Th17 cells, protects macrophages from oxidised lipids and aids clearance of necrotic debris after acute kidney injury.
CD5L stands for CD5 molecule like, and UniProt calls it CD5 antigen-like. Aliases include Spalpha and API6. Previous names include apoptosis inhibitor 6 and CD5 antigen-like (scavenger receptor cysteine rich family). UniProt lists secreted and cytoplasmic locations.
A mouse ortholog, Cd5l, exists. The function annotation connects CD5L to obesity-associated inflammation and autoimmunity, atherosclerosis, microbial infection and acute kidney injury. Check the datasheet of any product for its validated reactivity.
Other scavenger receptor family members, macrophage markers and lipid-metabolism and immune pathway partners related to CD5L.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O43866; product specifications from Assay Genie datasheets.